198 related articles for article (PubMed ID: 31305527)
21. Midbrain Organoids: A New Tool to Investigate Parkinson's Disease.
Smits LM; Schwamborn JC
Front Cell Dev Biol; 2020; 8():359. PubMed ID: 32509785
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease.
Venkatesh K; Sen D
Curr Stem Cell Res Ther; 2017; 12(4):326-347. PubMed ID: 27842480
[TBL] [Abstract][Full Text] [Related]
23. Regenerative medicine for Parkinson's disease using differentiated nerve cells derived from human buccal fat pad stem cells.
Takahashi H; Ishikawa H; Tanaka A
Hum Cell; 2017 Apr; 30(2):60-71. PubMed ID: 28210976
[TBL] [Abstract][Full Text] [Related]
24. Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.
Sison SL; Vermilyea SC; Emborg ME; Ebert AD
Curr Neurol Neurosci Rep; 2018 Oct; 18(12):84. PubMed ID: 30284665
[TBL] [Abstract][Full Text] [Related]
25. Combining Automated Organoid Workflows with Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond.
Renner H; Schöler HR; Bruder JM
Mov Disord; 2021 Dec; 36(12):2745-2762. PubMed ID: 34498298
[TBL] [Abstract][Full Text] [Related]
26. Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis.
Farzanehfar P
Neurochem Res; 2016 Dec; 41(12):3161-3170. PubMed ID: 27613619
[TBL] [Abstract][Full Text] [Related]
27. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
Chen W; Huang Q; Ma S; Li M
ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
[TBL] [Abstract][Full Text] [Related]
28. Animal models for Parkinson's disease.
Patil DA; Patil VA; Bari SB; Surana SJ; Patil PO
CNS Neurol Disord Drug Targets; 2014; 13(9):1580-94. PubMed ID: 25106631
[TBL] [Abstract][Full Text] [Related]
29. Emerging restorative treatments for Parkinson's disease: manipulation and inducement of dopaminergic neurons from adult stem cells.
Zhao J; Xu Q
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):509-16. PubMed ID: 21495964
[TBL] [Abstract][Full Text] [Related]
30. A robust protocol for the generation of human midbrain organoids.
Zagare A; Gobin M; Monzel AS; Schwamborn JC
STAR Protoc; 2021 Jun; 2(2):100524. PubMed ID: 34027482
[TBL] [Abstract][Full Text] [Related]
31. Pluripotent Stem Cells for Modelling and Cell Therapy of Parkinson's Disease.
Lebedeva OS; Lagarkova MA
Biochemistry (Mosc); 2018 Sep; 83(9):1046-1056. PubMed ID: 30472943
[TBL] [Abstract][Full Text] [Related]
32. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
[TBL] [Abstract][Full Text] [Related]
33. Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.
Alizadeh R; Kamrava SK; Bagher Z; Farhadi M; Falah M; Moradi F; Boroujeni ME; Soleimani M; Kamyab A; Komeili A
Neurosci Lett; 2019 Mar; 696():52-59. PubMed ID: 30552942
[TBL] [Abstract][Full Text] [Related]
34. Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons.
Suzuki S; Akamatsu W; Kisa F; Sone T; Ishikawa KI; Kuzumaki N; Katayama H; Miyawaki A; Hattori N; Okano H
Biochem Biophys Res Commun; 2017 Jan; 483(1):88-93. PubMed ID: 28057485
[TBL] [Abstract][Full Text] [Related]
35. 3D heterogeneous islet organoid generation from human embryonic stem cells using a novel engineered hydrogel platform.
Candiello J; Grandhi TSP; Goh SK; Vaidya V; Lemmon-Kishi M; Eliato KR; Ros R; Kumta PN; Rege K; Banerjee I
Biomaterials; 2018 Sep; 177():27-39. PubMed ID: 29883914
[TBL] [Abstract][Full Text] [Related]
36. Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF.
Yang F; Liu Y; Tu J; Wan J; Zhang J; Wu B; Chen S; Zhou J; Mu Y; Wang L
Nat Commun; 2014 Dec; 5():5627. PubMed ID: 25517983
[TBL] [Abstract][Full Text] [Related]
37. Human brain development through the lens of cerebral organoid models.
Andrews MG; Nowakowski TJ
Brain Res; 2019 Dec; 1725():146470. PubMed ID: 31542572
[TBL] [Abstract][Full Text] [Related]
38. BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons
Jovanovic VM; Salti A; Tilleman H; Zega K; Jukic MM; Zou H; Friedel RH; Prakash N; Blaess S; Edenhofer F; Brodski C
J Neurosci; 2018 Feb; 38(7):1662-1676. PubMed ID: 29321139
[TBL] [Abstract][Full Text] [Related]
39. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
Ho BX; Pek NMQ; Soh BS
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
[TBL] [Abstract][Full Text] [Related]
40. One Step Into the Future: New iPSC Tools to Advance Research in Parkinson's Disease and Neurological Disorders.
Mohamed NV; Larroquette F; Beitel LK; Fon EA; Durcan TM
J Parkinsons Dis; 2019; 9(2):265-281. PubMed ID: 30741685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
